Anticancer Activity of Diarachidonyl Phosphatidyl Choline Liposomal Curcumin Coated with Chitosan Against Breast and Pancreatic Cancer Cells

dc.contributor.authorEl-Kurdi, Riham
dc.contributor.authorMesmar, Joelle Edward
dc.contributor.authorEstephan, Maria
dc.contributor.authorBadran, Adnan
dc.contributor.authorBaydoun, Elias Abdel Hasan
dc.contributor.authorPatra, Digambara
dc.contributor.departmentDepartment of Chemistry
dc.contributor.departmentDepartment of Biology
dc.contributor.facultyFaculty of Arts and Sciences (FAS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:22:26Z
dc.date.available2025-01-24T11:22:26Z
dc.date.issued2022
dc.description.abstractThe distinctive capacity of liposomal systems to entrap both lipophilic and hydrophilic compounds allows the encapsulation of different kinds of drugs into these vesicles. Curcumin is known for its poor aqueous solubility, low bioavailability, and rapid metabolism. To inhibit these limitations, curcumin is mainly encapsulated in liposomes. Generally, DMPC, DPPC, and DSPC liposomes are widely used as a vehicle to encapsulate curcumin. Thus, in our work, curcumin was encapsulated, for the first time, into the bilayer of diarachidonyl phosphatidyl choline liposomes (DAPC), coated by a protective layer using chitosan oligosaccharides lactate (DAPC-Cur-COL NCs). Our results showed that DAPC liposomes ensured an encapsulation efficiency equal to 90% due to its long carbonyl chain compared to others liposomes. Hence, the presence of chitosan increased the encapsulation efficiency of curcumin to 99.40%. The formed nanocapsules were small in size and their anticancer potential was investigated. Interestingly, DAPC-Cur-COL NCs inhibited the proliferation of MCF-7 and Capan-1 cell lines by 85% and 90%, respectively. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
dc.identifier.doihttps://doi.org/10.1007/s12668-022-01019-4
dc.identifier.eid2-s2.0-85136224998
dc.identifier.urihttp://hdl.handle.net/10938/25509
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofBioNanoScience
dc.sourceScopus
dc.subjectCancer
dc.subjectCapan-1
dc.subjectCurcumin
dc.subjectDapc
dc.subjectMcf-7
dc.subjectBiochemistry
dc.subjectCancer cells
dc.subjectCell culture
dc.subjectChitosan
dc.subjectDiseases
dc.subjectDrug delivery
dc.subjectEfficiency
dc.subjectDiarachidonyl phosphatidyl choline
dc.subjectDipalmitoylphosphatidylcholine
dc.subjectLiposome
dc.subjectNanocapsule
dc.subjectOligosaccharide
dc.subjectPhosphatidylcholine
dc.subjectUnclassified drug
dc.subjectAnticancer activities
dc.subjectBreast cancer
dc.subjectDiarachidonyl phosphatidyl choline liposome
dc.subjectEncapsulation efficiency
dc.subjectPancreatic cancers
dc.subjectPhosphatidyl choline
dc.subjectAntineoplastic activity
dc.subjectArticle
dc.subjectCapan-1 cell line
dc.subjectCell viability assay
dc.subjectEncapsulation
dc.subjectHuman
dc.subjectHuman cell
dc.subjectIc50
dc.subjectMcf-7 cell line
dc.subjectMtt assay
dc.subjectPancreas cancer
dc.subjectPhoton correlation spectroscopy
dc.subjectSpectrofluorometry
dc.subjectX ray diffraction
dc.subjectZeta potential
dc.subjectLiposomes
dc.titleAnticancer Activity of Diarachidonyl Phosphatidyl Choline Liposomal Curcumin Coated with Chitosan Against Breast and Pancreatic Cancer Cells
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1331.pdf
Size:
1.47 MB
Format:
Adobe Portable Document Format